Clinical features and molecular epidemiology of CMY-type β-lactamase-producing Escherichia coli

Clinical Infectious Diseases

Volumn 48, Issue 6, 2009, Pages 739-744

  Sidjabat, Hanna E ^a   Paterson, David L ^a,b   Qureshi, Zubair A ^a   Adams Haduch, Jennifer M ^a   O'Keefe, Alexandra ^a   Pascual, Alvaro ^c   Rodríguez Bão, Jesús ^c   Doi, Yohei ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE AMPC; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; BACTERIAL DNA; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; CMY TYPE BETA LACTAMASE PRODUCING ESCHERICHIA COLI; COHORT ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; PYELONEPHRITIS; RETROSPECTIVE STUDY; URINARY TRACT INFECTION; AGED; BIOSYNTHESIS; CLASSIFICATION; CLUSTER ANALYSIS; DNA FINGERPRINTING; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOLOGY; PHYLOGENY; PLASMID; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; PLASMIDS; UNITED STATES;

EID: 62449219508     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597037     Document Type: Article

References (20)

1. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989;17:316-21.
2. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
3. Walther-Rasmussen J, Hoiby N. Plasmid-borne AmpC β-lactamases. Can J Microbiol 2002;48:479-93.
4. Doi Y, Paterson DL. Detection of plasmid-mediated class C β-lactamases. Int J Infect Dis 2007;11:191-7.
5. Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007;13:443-8.
6. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother 2008;52:3814-6.
7. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 17th informational supplement. M100-S17. Wayne, PA: CLSI, 2007.
8. Yagi T, Wachino J, Kurokawa H, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005;43:2551-8.
9. Garcia Dde O, Doi Y, Szabo D, et al. Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob Agents Chemother 2008;52:1790-3.
10. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004.
11. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8.
12. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261-72.
13. Picard B, Garcia JS, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999;67:546-53.
14. Sambrook J, Russell DW. Molecular cloning. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
15. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004;48:533-7.
16. Mammeri H, Eb F, Berkani A, Nordmann P. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J Antimicrob Chemother 2008;61:498-503.
17. Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and carbapenem-hydrolyzing β-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol 2006;44:1971-6.
18. Brenwald NP, Jevons G, Andrews J, Ang L, Fraise AP. Disc methods for detecting AmpC β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 2005;56:600-1.
19. Endimiani A, Doi Y, Bethel CR, et al. CMY-32, a novel β-lactamase of the CMY-2 family with enhanced susceptibility to sulfone inhibitors [abstract C1-888]. In: Program and abstracts of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 2008; 113.
20. Garcia-Fernandez A, Chiaretto G, Bertini A, et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin. J Antimicrob Chemother 2008;61:1229-33.